Q3 Earnings Alert! Plan early for this week’s stock reports with all key data in 1 placeSee list

Sanofi SA (SASY)

Paris
Currency in EUR
Disclaimer
100.14
-0.46(-0.46%)
Closed
SASY Scorecard
Full Analysis
Has raised its dividend for 25 consecutive years
Earnings results expected in 14 days
Fair Value
Day's Range
100.00100.68
52 wk Range
80.60106.14
Prev. Close
100.6
Open
100.26
Day's Range
100-100.68
52 wk Range
80.6-106.14
Volume
1,057,009
Average Volume (3m)
1,431,466
1-Year Change
-2.63%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
SASY Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
106.15
Upside
+6.00%
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with low price volatility
Show more

Sanofi Company Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as dupixent, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers body lotions, anti-itch products, moisturizing and soothing lotions, body and foot creams, and eczema powders. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for Parkinson's disease; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Amunix Pharmaceuticals, Inc for T-cell engagers and cytokine therapies. It also enters in a strategic collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.

Employees
91573
Market
France

Compare SASY to Peers and Sector

Metrics to compare
SASY
Peers
Sector
Relationship
P/E Ratio
0.0x19.7x−0.6x
PEG Ratio
−0.590.110.00
Price/Book
0.0x2.4x2.6x
Price / LTM Sales
0.0x2.9x3.2x
Upside (Analyst Target)
13.2%1.9%48.5%
Fair Value Upside
Unlock15.2%7.8%Unlock

FAQ

What Is the Sanofi (SASY) Stock Price Today?

The Sanofi stock price today is 100.14.

What Stock Exchange Does Sanofi Trade On?

Sanofi is listed and trades on the Paris stock exchange.

What Is the Stock Symbol for Sanofi?

The stock symbol for Sanofi is "SASY."

Does Sanofi Pay Dividends? What’s The Current Dividend Yield?

The dividend yield is 3.87%.

What Is the Sanofi Market Cap?

As of today, Sanofi market cap is 125.52B.

What is Sanofi Earnings Per Share?

The Sanofi EPS is 7.24.

What Is the Next Sanofi Earnings Date?

Sanofi will release its next earnings report on 24 Oct 2024.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.